Structural studies of complexes of kallikrein 4 with wild-type and mutated forms of the Kunitz-type inhibitor BbKI
Language English Country United States Media print-electronic
Document type Journal Article
Grant support
HHSN261200800001C
CCR NIH HHS - United States
HHSN261200800001E
NCI NIH HHS - United States
RVO 61388963
Ústav organické chemie a biochemie Akademie věd České republiky
CZ.02.1.01/0.0/0.0/16_019/0000729
European Regional Development Fund
PubMed
34342281
PubMed Central
PMC8329858
DOI
10.1107/s2059798321006483
PII: S2059798321006483
Knihovny.cz E-resources
- Keywords
- Bauhinia bauhinioides, BbKI, chymotrypsin, human kallikrein 4, kallikreins, plant Kunitz inhibitors, proteases, protein–protein interactions, trypsin,
- MeSH
- Bauhinia metabolism MeSH
- Kallikreins chemistry metabolism MeSH
- Mutation MeSH
- Plant Proteins chemistry metabolism MeSH
- Protein Binding MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Kallikreins MeSH
- kallikrein 4 MeSH Browser
- Plant Proteins MeSH
Structures of BbKI, a recombinant Kunitz-type serine protease inhibitor from Bauhinia bauhinioides, complexed with human kallikrein 4 (KLK4) were determined at medium-to-high resolution in four crystal forms (space groups P3121, P6522, P21 and P61). Although the fold of the protein was virtually identical in all of the crystals, some significant differences were observed in the conformation of Arg64 of BbKI, the residue that occupies the S1 pocket in KLK4. Whereas this residue exhibited two orientations in the highest resolution structure (P3121), making either a canonical trypsin-like interaction with Asp189 of KLK4 or an alternate interaction, only a single alternate orientation was observed in the other three structures. A neighboring disulfide, Cys191-Cys220, was partially or fully broken in all KLK4 structures. Four variants of BbKI in which Arg64 was replaced by Met, Phe, Ala and Asp were expressed and crystallized, and their structures were determined in complex with KLK4. Structures of the Phe and Met variants complexed with bovine trypsin and of the Phe variant complexed with α-chymotrypsin were also determined. Although the inhibitory potency of these variant forms of BbKI was lowered by up to four orders of magnitude, only small changes were seen in the vicinity of the mutated residues. Therefore, a totality of subtle differences in KLK4-BbKI interactions within the fully extended interface in the structures of these variants might be responsible for the observed effect. Screening of the BbKI variants against a panel of serine proteases revealed an altered pattern of inhibitory specificity, which was shifted towards that of chymotrypsin-like proteases for the hydrophobic Phe and Met P1 substitutions. This work reports the first structures of plant Kunitz inhibitors with S1-family serine proteases other than trypsin, as well as new insights into the specificity of inhibition of medically relevant kallikreins.
See more in PubMed
Araújo, A. P. U., Hansen, D., Vieira, D. F., Oliveira, C., Santana, L. A., Beltramini, L. M., Sampaio, C. A. M., Sampaio, M. U. & Oliva, M. L. V. (2005). Biol. Chem. 386, 561–568. PubMed
Bao, R., Zhou, C.-Z., Jiang, C., Lin, S.-X., Chi, C.-W. & Chen, Y. (2009). J. Biol. Chem. 284, 26676–26684. PubMed PMC
Batista, I. F. C., Oliva, M. L. V., Araujo, M. S., Sampaio, M. U., Richardson, M., Fritz, H. & Sampaio, C. A. M. (1996). Phytochemistry, 41, 1017–1022. PubMed
Botos, I. & Wlodawer, A. (2007). Curr. Opin. Struct. Biol. 17, 683–690. PubMed PMC
Brito, M. V., de Oliveira, C., Salu, B. R., Andrade, S. A., Malloy, P. M. D., Sato, A. C., Vicente, C. P., Sampaio, M. U., Maffei, F. H. A. & Oliva, M. L. V. (2014). Thromb. Res. 133, 945–951. PubMed
Burmeister, W. P. (2000). Acta Cryst. D56, 328–341. PubMed
Cereda, V., Formica, V., Menghi, A., Pellicori, S. & Roselli, M. (2015). Expert Opin. Investig. Drugs, 24, 929–947. PubMed
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S. & Richardson, D. C. (2010). Acta Cryst. D66, 12–21. PubMed PMC
Czapinska, H., Helland, R., Smalås, A. O. & Otlewski, J. (2004). J. Mol. Biol. 344, 1005–1020. PubMed
Debela, M., Goettig, P., Magdolen, V., Huber, R., Schechter, N. M. & Bode, W. (2007). J. Mol. Biol. 373, 1017–1031. PubMed
Debela, M., Hess, P., Magdolen, V., Schechter, N. M., Steiner, T., Huber, R., Bode, W. & Goettig, P. (2007). Proc. Natl Acad. Sci. USA, 104, 16086–16091. PubMed PMC
DeLano, W. L. (2002). PyMOL. http://www.pymol.org.
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. PubMed PMC
Gong, W., Liu, Y., Seidl, C., Dreyer, T., Drecoll, E., Kotzsch, M., Bronger, H., Dorn, J. & Magdolen, V. (2019). PLoS One, 14, e0212968. PubMed PMC
Helland, R., Czapinska, H., Leiros, I., Olufsen, M., Otlewski, J. & Smalås, A. O. (2003). J. Mol. Biol. 333, 845–861. PubMed
Helland, R., Otlewski, J., Sundheim, O., Dadlez, M. & Smalås, A. O. (1999). J. Mol. Biol. 287, 923–942. PubMed
Horn, M., Zbodakova, O., Kasparek, P., Srp, J., Haneckova, R., Hradilek, M., Mares, M. & Sedlacek, R. (2018). Biol. Chem. 399, 1085–1089. PubMed
Kalinska, M., Meyer-Hoffert, U., Kantyka, T. & Potempa, J. (2016). Biochimie, 122, 270–282. PubMed PMC
Krissinel, E. & Henrick, K. (2007). J. Mol. Biol. 372, 774–797. PubMed
Laskowski, M. Jr & Kato, I. (1980). Annu. Rev. Biochem. 49, 593–626. PubMed
Li, M., Srp, J., Gustchina, A., Dauter, Z., Mares, M. & Wlodawer, A. (2019). Acta Cryst. D75, 56–69. PubMed PMC
Lobo, Y. A., Bonazza, C., Batista, F. P., Castro, R. A., Bonturi, C. R., Salu, B. R., de Cassia Sinigaglia, R., Toma, L., Vicente, C. M., Pidde, G., Tambourgi, D. V., Alvarez-Flores, M. P., Chudzinski-Tavassi, A. M. & Oliva, M. L. V. (2020). Cancer Lett. 491, 108–120. PubMed
Majumder, S., Khamrui, S., Dasgupta, J., Dattagupta, J. K. & Sen, U. (2012). Biochim. Biophys. Acta, 1824, 882–890. PubMed
Mavridis, K., Avgeris, M. & Scorilas, A. (2014). Expert Opin. Ther. Targets, 18, 365–383. PubMed
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674. PubMed PMC
Murafuji, H., Sakai, H., Goto, M., Imajo, S., Sugawara, H. & Muto, T. (2017). Bioorg. Med. Chem. Lett. 27, 5272–5276. PubMed
Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011). Acta Cryst. D67, 355–367. PubMed PMC
Nakahata, A. M., Mayer, B., Neth, P., Hansen, D., Sampaio, M. U. & Oliva, M. L. V. (2013). Planta Med. 79, 227–235. PubMed
Nishimiya, D., Kawaguchi, Y., Kodama, S., Nasu, H., Yano, H., Yamaguchi, A., Tamura, M. & Hashimoto, R. (2019). Sci. Rep. 9, 11436. PubMed PMC
Odei-Addo, F., Frost, C., Smith, N., Ogawa, T., Muramoto, K., Oliva, M. L. V., Gráf, L. & Naude, R. (2014). J. Enzyme Inhib. Med. Chem. 29, 633–638. PubMed
Oliva, M. L. V., Mendes, C. R., Juliano, M. A., Chagas, J. R., Rosa, J. C., Greene, L. J., Sampaio, M. U. & Sampaio, C. A. M. (1999). Immunopharmacology, 45, 163–169. PubMed
Oliva, M. L. V., Mendes, C. R., Santomauro-Vaz, E. M., Juliano, M. A., Mentele, R., Auerswald, E. A., Sampaio, M. U. & Sampaio, C. A. M. (2001). Curr. Med. Chem. 8, 977–984. PubMed
Oliva, M. L. V. & Sampaio, U. M. (2008). Biol. Chem. 389, 1007–1013. PubMed
Oliva, M. L. V., Silva, M. C. C., Sallai, R. C., Brito, M. V. & Sampaio, M. U. (2010). Biochimie, 92, 1667–1673. PubMed
Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326. PubMed
Pampalakis, G. & Sotiropoulou, G. (2007). Biochim. Biophys. Acta, 1776, 22–31. PubMed
Patil, D. N., Chaudhary, A., Sharma, A. K., Tomar, S. & Kumar, P. (2012). FEBS J. 279, 4547–4564. PubMed
Prassas, I., Eissa, A., Poda, G. & Diamandis, E. P. (2015). Nat. Rev. Drug Discov. 14, 183–202. PubMed
Ravelli, R. B. G. & McSweeney, S. M. (2000). Structure, 8, 315–328. PubMed
Renko, M., Sabotič, J. & Turk, D. (2012). Biol. Chem. 393, 1043–1054. PubMed
Riley, B. T., Hoke, D. E., McGowan, S. & Buckle, A. M. (2019). Acta Cryst. F75, 543–546. PubMed PMC
Riley, B. T., Ilyichova, O., Costa, M. G., Porebski, B. T., de Veer, S. J., Swedberg, J. E., Kass, I., Harris, J. M., Hoke, D. E. & Buckle, A. M. (2016). Sci. Rep. 6, 35385. PubMed PMC
Riley, B. T., Ilyichova, O., de Veer, S. J., Swedberg, J. E., Wilson, E., Hoke, D. E., Harris, J. M. & Buckle, A. M. (2019). Biochemistry, 58, 2524–2533. PubMed
Shelley, K. L., Dixon, T. P. E., Brooks-Bartlett, J. C. & Garman, E. F. (2018). J. Appl. Cryst. 51, 552–559. PubMed PMC
Song, H. K. & Suh, S. W. (1998). J. Mol. Biol. 275, 347–363. PubMed
Sotiropoulou, G. & Pampalakis, G. (2012). Trends Pharmacol. Sci. 33, 623–634. PubMed
Souza-Pinto, J. C., Oliva, M. L., Sampaio, C. A., Damas, J., Auerswald, E. A., Limaos, E., Fritz, H. & Sampaio, M. U. (1996). Immunopharmacology, 33, 330–332. PubMed
Turk, B. (2006). Nat. Rev. Drug Discov. 5, 785–799. PubMed
Vadivel, K., Ponnuraj, S. M., Kumar, Y., Zaiss, A. K., Bunce, M. W., Camire, R. M., Wu, L., Evseenko, D., Herschman, H. R., Bajaj, M. S. & Bajaj, S. P. (2014). J. Biol. Chem. 289, 31647–31661. PubMed PMC
Weik, M., Ravelli, R. B., Kryger, G., McSweeney, S., Raves, M. L., Harel, M., Gros, P., Silman, I., Kroon, J. & Sussman, J. L. (2000). Proc. Natl Acad. Sci. USA, 97, 623–628. PubMed PMC
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., McNicholas, S. J., Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read, R. J., Vagin, A. & Wilson, K. S. (2011). Acta Cryst. D67, 235–242. PubMed PMC
Zhou, D., Hansen, D., Shabalin, I. G., Gustchina, A., Vieira, D. F., de Brito, M. V., Araújo, A. P. U., Oliva, M. L. V. & Wlodawer, A. (2015). Acta Cryst. F71, 1055–1062. PubMed PMC
Zhou, D., Lobo, Y. A., Batista, I. F., Marques-Porto, R., Gustchina, A., Oliva, M. L. & Wlodawer, A. (2013). PLoS One, 8, e62252. PubMed PMC